Updates on the respiratory illness that has infected more than one million people and killed tens of thousands.
Coronavirus and COVID-19
Nature wades through the literature on COVID-19 so you don’t have to.
How epidemiologists rushed to model the coronavirus pandemic.
The World Health Organization says the evidence is not compelling, but scientists warn that gathering sufficient data could take years and cost lives.
Snapshots from four nations struggling to limit deaths faster than the United States and other wealthy countries.
Other countries on lockdown will be watching for a resurgence of infections in Hubei province now that travel restrictions are lifting.
Radical proposal to conduct ‘human challenge’ studies could dramatically speed up vaccine research.
New York City researchers hope antibody-rich plasma can keep people out of intensive care.
Scientists are teaming up to fight COVID-19. Presidents and prime ministers should, too.
But scientists say it’s unclear whether felines can spread the virus to people, so pet owners need not panic yet.
A reduction in seismic noise because of changes in human activity is a boon for geoscientists.
Many major facilities have essentially shut down, but some are soldiering on.
As universities scale back operations and scientists observe stay-at-home orders, many are struggling to protect their research and the animals that power it.
Economic bailouts could bolster green growth — or delay action and boost emissions.
Unheeded lessons from simulations of health and other disasters could still assist recovery.
Governments need to think twice before they suppress messages related to COVID-19.
As labs shut down around the world, researchers are finding creative ways to donate their time, supplies and expertise.
Could blood plasma from coronavirus survivors be an effective short-term treatment for patients?
Close confines help the virus to spread, but closed environments are also an ideal place to study how the new coronavirus behaves.
In the first of two articles about laboratory closures triggered by COVID-19, scientists affected by the shutdowns outline the tools they are using to run their research groups remotely.
Feeling overwhelmed by a lockdown and the need to suddenly adopt e-learning? Keep connected and compassionate, says clinical psychologist Desiree Dickerson.
Studies grind to a halt as fears of health-care shortages and risk of exposure put the brakes on clinical research.
Share data, boost incentives and reduce red tape to identify drugs for use in emerging coronavirus epidemics.
NASA halts work on the US$8.8-billion James Webb Space Telescope, which was due to launch next year.
Research will offer the best exit strategy, and we will do everything we can to help researchers and clinicians realize that goal.
Universities are closing worldwide, forcing instructors to turn to remote teaching. Here’s some expert advice on how to embrace the digital classroom.
Nature examines how viral diagnostic tests work, why testing has varied around the world and the CRISPR-based tests under development to fight COVID-19.
Scientists are rushing to estimate the proportion of people with mild or no symptoms who could be spreading the pathogen.
US authorities are failing to test people and notify their contacts, a cornerstone of outbreak response.
If testing and contact tracing are key to controlling the coronavirus outbreak, why aren’t they being done around the world?
Doing science during the quarantine in northern Italy has shown me that creativity needs connection. By Alberto Bardelli
Some experts warn that accelerated testing will involve some risky trade-offs.
From papers published to carbon emissions to confirmed cases, these data reveal an unprecedented viral outbreak and its impacts around the world.
Researchers are studying the effects of China’s lockdowns to glean insights about controlling the viral pandemic.
Follow World Health Organization advice, end secrecy in decision-making and cooperate globally.
Extensive contact tracing has slowed viral spread, but some say publicizing people’s movements raises privacy concerns.
Nick Howe investigates how researchers around the world are answering the call for science.
As scientific meetings are cancelled worldwide, researchers are rethinking how they network — a move that some say is long overdue.
We must urgently develop measures to tackle the new coronavirus — but safety always comes first, says Shibo Jiang.
Three leading health officials talk about gauging the size of local outbreaks, and why containment strategies aren’t futile yet.
The launch is on track for July, as Europe and Russia announce a two-year delay in their journey to the red planet.
A team member on the huge project has tested positive for the virus, delaying a mission to take measurements from the air.
Mice originally bred for SARS research are in high demand.
Researchers have identified microscopic features that could make the pathogen more infectious than the SARS virus — and serve as drug targets.
As cases in Washington state soar, virologists are working around the clock to diagnose cases, reveal routes of transmission and test treatments.
Despite COVID-19’s spread to new countries, the evidence suggests it is yet possible to curb the virus.
Physicists who were set to attend the American Physical Society’s Denver conference are using virtual platforms to share their talks.
Pangolins are a prime suspect, but a slew of genetic analyses has yet to find conclusive proof.
As outbreaks surge worldwide, scientists fear that COVID-19 might soon become pandemic.
From laboratory closures to equipment shortages, researchers worldwide tell Nature how they have been affected by the epidemic.
Wild-animal markets are the suspected origin of the current outbreak and the 2002 SARS outbreak.
Researchers say that excluding these people could conceal the epidemic’s true extent, but others say the practice makes sense.
Officials want to know but predictions vary wildly, from now to after hundreds of millions of people are infected.
As HIV drugs, stem cells and traditional Chinese medicines vie for a chance to prove their worth, the World Health Organization attempts to bring order to the search.
Concerns are rising about the virus’s potential to circulate undetected in Africa and Asia.
Use techniques honed during the SARS, H1N1 and Ebola epidemics to separate sick and well, keep workers safe and prepare for the next outbreak, says Nahid Bhadelia
World leaders and international donors must strengthen the most vulnerable nations’ health-care systems.
Reporter Heidi Ledford explains three key fields of research
Genetic sequences of viruses isolated from the scaly animals are 99% similar to that of the circulating virus — but the work is yet to be formally published.
As the new coronavirus continues its deadly spread, researchers must ensure that their work on this outbreak is shared rapidly and openly.
Scientists need the pathogen to probe the biology of the emerging infection and to develop tests, drugs and vaccines.
Experts weigh up the best- and worst-case scenarios as the World Health Organization declares a global health emergency.
Research papers and preprints are appearing every day as researchers worldwide respond to the outbreak.
Structural biologist Rolf Hilgenfeld has been working on coronavirus treatments since the SARS outbreak.
How science can help control the outbreak
Measures to contain a new virus’s spread have cut off the city's researchers.
One genetic analysis suggests reptilian reservoir — but researchers doubt that the coronavirus could have originated in animals other than birds or mammals.
Researchers are racing to find out more about the epidemiology and genetic sequence of the coronavirus spreading in Asia and beyond.
Vigilance, preparedness, speed, transparency and global coordination are now crucial to stopping a new infectious disease from becoming a global emergency.
Chinese officials have confirmed that the virus is spreading between people, but it’s still unclear how easily this happens.
Chinese officials reported more than 100 new infections and South Korea confirmed its first case.
The legacy of SARS has haunted the race to understand a respiratory infection that has affected 60 people.